Related Experiment Video
Updated: Aug 13, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Advances in the Treatment of Pediatric Brain Tumors
Edwin S Kulubya1, Matthew J Kercher1, H Westley Phillips2
1Department of Neurosurgery, University of California Davis, Sacramento, CA 95817, USA.
Abstract:
Pediatric brain tumors are the most common solid malignancies in children. Advances in the treatment of pediatric brain tumors have come in the form of imaging, biopsy, surgical techniques, and molecular profiling. This has led the way for targeted therapies and immunotherapy to be assessed in clinical trials for the most common types of pediatric brain tumors. Here we review the latest efforts and challenges in targeted molecular therapy, immunotherapy, and newer modalities such as laser interstitial thermal therapy.
Insights
Pediatric brain tumors are the most common childhood solid tumors. Advances in imaging, biopsy, surgery, and molecular profiling are driving new targeted therapies and immunotherapies for these challenging cancers.
Area of Science:
- Pediatric oncology
- Neuro-oncology
- Cancer research
Background:
- Pediatric brain tumors represent the most frequent solid malignancies in children.
- Significant progress in pediatric brain tumor treatment has been achieved through advancements in diagnostic imaging, biopsy techniques, surgical procedures, and molecular profiling.
- These advancements facilitate the evaluation of novel therapeutic strategies in clinical trials.
Purpose of the Study:
- To review recent progress and persistent challenges in the treatment of pediatric brain tumors.
- To highlight the evolving landscape of targeted molecular therapies and immunotherapies.
- To discuss emerging treatment modalities like laser interstitial thermal therapy.
Main Methods:
- Literature review of recent advancements in pediatric brain tumor treatment.
- Analysis of clinical trial data for targeted therapies and immunotherapies.
- Examination of novel treatment approaches, including laser interstitial thermal therapy.
Main Results:
- Molecular profiling has enabled the development of targeted therapies for specific pediatric brain tumor subtypes.
- Immunotherapy approaches are showing promise in early-phase clinical trials.
- Laser interstitial thermal therapy offers a minimally invasive option for select cases.
Conclusions:
- Continued research and clinical trials are crucial for optimizing targeted and immunotherapies for pediatric brain tumors.
- Integrating molecular profiling into treatment decisions is key to personalized medicine.
- Emerging technologies like laser interstitial thermal therapy expand treatment options, improving outcomes for children with brain tumors.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023